Risks

Net debt to EBITDA of 16.7x and negative interest coverage indicate materially tighter balance-sheet flexibility than most peers, increasing refinancing sensitivity if operating conditions soften.

Days sales outstanding of 47.5 and a 27-day cash conversion cycle suggest working-capital drag versus faster-turning peers, which can constrain cash generation in a downturn.

Current and quick ratios of 4.7x provide liquidity support, but the negative coverage profile means lenders may still price CTM more conservatively than better-covered peers.

The absence of reported FCF margin limits visibility on self-funding capacity, leaving CTM more exposed than peers with clearer free-cash-flow conversion if growth slows.

Opportunities

A 4.7x current ratio gives CTM more near-term liquidity than many leveraged peers, supporting operating continuity while the company works through elevated debt metrics.

Low debt-to-equity of 0.03x can help CTM appear less equity-stretched than peers, which may preserve strategic flexibility if earnings recover and leverage normalizes.

A modest 27-day cash conversion cycle is not best-in-class, but it is manageable versus slower-turning peers and can support incremental cash release if collections improve.

If operating performance stabilizes, the combination of strong liquidity and low equity leverage could allow CTM to narrow the gap versus peers with weaker balance-sheet buffers.

Overall Score

CTM’s forward positioning is constrained by very high net leverage and negative interest coverage, while strong liquidity and manageable working capital provide some offset versus peers.